|
DNA | Ginkgo Bioworks Holdings, Inc. |
|
|
DNA | Ginkgo Bioworks Holdings, Inc. |
| Biological Products (no Diagnostic Substances) |
| Book value per $ invested | $ 0.04 |
| Leverage | 54.58% |
| Market Cap | $ 13.9B |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -312.2m |
| Margin | -181.74% |
None